Last reviewed · How we verify

NCT07076771

Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males

Recruiting now Last updated 22 July 2025
What this trial tests

trial testing Coronary Angiography in Testosterone in 50 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
1 August 2025
1 August 2025

Quick facts

Lead sponsorSohag University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 January 2025
Primary completion1 August 2025
Estimated completion1 August 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Under 45, male only, with Testosterone or Angiographic Complexity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the association between serum testosterone levels and the angiographic complexity of coronary artery lesions in male patients under 45 years of age presenting with premature ischemic heart disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Coronary Angiography

Trials testing the same drug.

Other recruiting trials for Testosterone

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07076771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing